ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Pharming Group N.V. 

P.O. Box 451

AL Leiden    2300  The Netherlands
Phone: 31-0-71-524-7400 Fax: +31-0-71-521-6507


SEARCH JOBS








 Company News
Pharming Group (PHGUF.PK) And Salix Pharmaceuticals, Ltd. (SLXP) Announce Initiation Of Clinical Study Of Ruconest® For Prophylaxis Of Hereditary Angioedema 8/28/2014 10:58:01 AM
Pharming Group (PHGUF.PK) Acquires New Product Leads Through The Acquisition Of Certain Assets Of TRM SASU For € 0.5 Million In Cash 8/19/2014 9:09:54 AM
Pharming Group (PHGUF.PK) Reports On Financial Results First Half Year 2014 7/31/2014 9:12:58 AM
Pharming Group (PHGUF.PK), Salix Pharmaceuticals, Ltd. (SLXP) Wins FDA Approval For Ruconest® 7/17/2014 8:27:12 AM
Pharming Group (PHGUF.PK) Reports On Financial Results First Quarter 2014 5/15/2014 9:00:36 AM
Pharming Group (PHGUF.PK) Announces ("Sub 10%") €14.7 Million Private Equity Placement With Institutional Investors 4/22/2014 8:08:39 AM
Pharming Group (PHGUF.PK) Reports On Preliminary Financial Results 2013 3/6/2014 9:04:51 AM
Salix Pharmaceuticals, Ltd. (SLXP), Pharming Group (PHGUF.PK) Announce Extension Of PDUFA Action Date For RUCONEST® 2/24/2014 6:44:49 AM
Pharming Group (PHGUF.PK) and Santarus Inc. (SNTS) Announce New Data From Open-Label Repeat Treatment Study With Rucomest 11/8/2013 9:08:34 AM
Santarus Inc. (SNTS) and Pharming Group (PHGUF.PK) Announce New Data From Open-Label Repeat Treatment Study With RUCONEST (Recombinant Human C1 Esterase Inhibitor) 11/8/2013 7:51:26 AM
12345678910...